small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (115)
  • Capabilities (44)
  • Experience (112)
  • Insights & News (846)
  • Other Results (36)

Professionals 115 results

Kate L. Price
Kate L. Price
Partner
  • Chicago
Email
+1 312-558-7927
vCard

Partner

  • Chicago
Conor Reidy
Conor Reidy
Partner
  • Chicago
Email
+1 312-558-7542
vCard

Partner

  • Chicago
Anthony Baker
Anthony Baker
Associate
  • Chicago
Email
+1 312-558-8133
vCard

Associate

  • Chicago
View All Professionals

Capabilities 44 results

Practice Area

Antitrust/Competition

Practice Area

Class Actions & Group Litigation

Winston has developed a consistent record of success handling class action cases in state and federal courts. The practice is anchored by seasoned class action lawyers, many of whom have been recognized by Chambers USA and other ranking organizations as being top practitioners in their field. Our clients rely on us to steer them through class action matters by drawing on the firm’s significant experience in resolving complex litigation using creative and aggressive arguments, across a broad range of class, collective, coordinated, and mass actions, as well multidistrict litigation. We also have succeeded at trial in several class actions—a rare occurrence....Read more

Industry

Life Sciences

Winston has been a major player in the life sciences industry for decades. We represent market-leading clients across this broad sector, including companies involved in pharmaceuticals, biologics, biosimilars, biotechnology, and medical devices. Our attorneys are seasoned practitioners—many of whom have technical degrees in areas key to the life sciences sector, including biology, chemistry, pharmacy, and biomedical engineering—and bring a unique understanding of the industry and perspective to our representations....Read more

Experience 112 results

Experience

|

December 3, 2025

US Tiger Securities Announced IPO

Winston & Strawn LLP is serving as U.S. securities counsel to US Tiger Securities, Inc., a full-service broker/dealer, in connection with the $10,000,000 initial public offering of SMJ International Holdings Inc., a Singapore-based premium flooring specialist. The Company priced 2,500,000 Class A ordinary shares at US$4.00 per share. The Class A ordinary shares are expected to begin trading on the NYSE American under the ticker symbol “SMJF” on December 4, 2025....Read more

Experience

|

October 1, 2025

AA Mission Acquisition Corp. II - Initial Public Offering

Winston & Strawn LLP represented AA Mission Acquisition Corp. II, a blank check company, in the recent closing of its $100 million Initial Public Offering (IPO). The offering consisted of 10,000,000 units priced at $10.00 per unit, before deducting underwriting discounts and estimated offering expenses. The units began trading on the New York Stock Exchange (NYSE) under the ticker symbol “YCY.U” on October 1, 2025....Read more

Experience

|

July 30, 2025

Following an Astounding Summary Judgment Win, Winston Secures Three Favorable Class Settlements in US$52+B Broiler Chicken Litigation

Represent Norman W. Fries, Inc. d/b/a Claxton Poultry Farms in a series of 15+ antitrust class actions consolidated in the Northern District of Illinois and brought by plaintiffs who allege that Claxton and the nation’s other largest poultry producers conspired to fix the price of broiler chickens in a scheme from 2008 to 2016 that raised the price for broiler chickens by artificially reducing supply....Read more
View All Experience

Insights & News 846 results

Seminar/CLE

|

January 20, 2026

2026 NYC SBIC Fund Conference

Winston & Strawn and RSM US LLP are co-hosting the annual NYC SBIC Fund Conference on Tuesday, January 20, 2026.General and limited partners, chief financial officers, and controllers of small business investment company (SBIC) funds are invited to a half-day seminar covering various topics related to SBIC fund operations, including:...Read more

Competition Corner

|

December 23, 2025

|

4 Min Read

The Continuing Expansion of Algorithmic Software Laws – Best Practices for Companies in an Evolving Landscape

New York recently expanded its algorithmic pricing laws, now requiring retailers to disclose when prices are set with algorithmic software based on consumers’ personal data.The so-called practice of surveillance pricing entails adjusting prices charged for goods and services according to monitored personal data.

Capital Markets & Securities Law Watch

|

December 22, 2025

|

3 Min Read

Wall Street Never Sleeps (And Now, Neither Does Nasdaq)

On December 15, 2025, the Nasdaq Stock Market LLC (Nasdaq) announced that it intends to formally seek Securities and Exchange Commission (SEC) approval to expand its weekday trading schedule to 23 hours per day, a significant increase from the current 16-hour framework. The proposal builds on earlier statements by Nasdaq President , Tal Cohen, indicating that Nasdaq has begun discussions with regulators regarding the expanded trading schedule and is targeting a potential launch in the second half of 2026.

View All Insights & News

Other Results 36 results

Site Content

What Is the Price Range in an IPO?

The price range is a proposed price per share range for the IPO within which investors can bid for shares and which is often printed on the cover page of a preliminary prospectus. The price range has a minimum price, known as the floor price, and a maximum price, known as the cap price....Read more

Site Content

What Is the BPCIA?

Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) to provide an abbreviated pathway for biosimilars to gain FDA approval through submission of an abbreviated Biologics License Application (aBLA)....Read more

Site Content

What Is Dilution?

Dilution refers to the reduction in an existing shareholder’s ownership percentage of a company when the company issues additional shares. Dilution in an IPO results from a disparity between the public offering price in an IPO and the effective cash cost to persons who acquired shares prior to the IPO. Dilution is disclosed in the registration statement in a dilution table....Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2026. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising